ELOCP35

Across TCGA pan-cancer cohorts, ELOCP35 RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated ELOCP35 data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher ELOCP35 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ELOCP35 expression acts as an unfavorable survival marker.

ESCA are the cancer types where ELOCP35 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

ELOCP35–ESCA (OS)

Open the ESCA breakdown →